Arteris Reports Record Q1 2026 Earnings Driven by AI Chip Demand
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 12 2026
0mins
Source: seekingalpha
Arteris Inc. stock rose by 10.24% as it reached a 52-week high, reflecting strong investor interest following its impressive earnings report.
The company reported a record annual contract value plus royalties of $92.8 million in Q1 2026, a 39% year-on-year increase, driven by robust demand for AI chips. Additionally, Arteris secured partnerships with a leading global hyperscaler and memory supplier, enhancing its market position in the automotive and data center sectors. CFO Hawkins raised guidance for FY 2026 revenue, expecting annual contract value to reach between $102 million and $106 million, indicating a positive outlook for profitability and cash flow.
This strong performance highlights Arteris's growth potential and solidifies its position in the semiconductor market, attracting investor confidence and contributing to the stock's upward movement.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AIP?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AIP
Wall Street analysts forecast AIP stock price to fall
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 43.590
Low
20.00
Averages
20.50
High
21.00
Current: 43.590
Low
20.00
Averages
20.50
High
21.00
About AIP
Arteris, Inc. is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its System IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. It provides semiconductor interconnect IP and SoC Integration Automation software solutions to serve its target end-markets, including automotive, enterprise computing, consumer electronics, communications across wired and wireless, and industrial markets. Its two core product platforms are Network-on-Chip IP Products and SoC Integration Automation Software Solutions Products. Its Network-on-Chip IP products include Non-coherent NoC IP, with FlexGen, FlexNoC and FlexWay; Cache-coherent NoC IP, with Ncore, and NoC interface IP, with CodaCache. Its SoC Integration Automation Software Solutions products include IP and SoC software, with Magillem (Connectivity and Registers) and CSRCompiler.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Arteris COO Sells 39,541 Shares for $1.71 Million
- Insider Selling: Laurent R Moll, COO of Arteris, disclosed a direct sale of 39,541 shares valued at approximately $1.71 million in his latest SEC filing, representing nearly 15% of his direct holdings and indicating a significant reduction in his stake.
- Ownership Changes: Post-transaction, Moll's direct holdings decreased to 227,296 shares, or about 0.49% of the company's outstanding shares, with 21 sales since March 2025 reducing his holdings by 57%, reflecting a continuous decline in his share capacity.
- Market Performance and Impact: While Moll's selling coincides with Arteris shares rallying nearly 348% over the past year, his frequent sales may raise investor concerns about the company's future performance, especially given that he has reduced his stake by nearly 60%.
- Investor Considerations: Although insider selling is often viewed as a negative signal, Moll's sales may relate to personal financial needs or wealth diversification, prompting investors to weigh his selling against Arteris's strong market performance when assessing the company.
See More
Arteris Insider Sale Raises Investor Concerns
- Insider Selling Details: Laurent R Moll, COO of Arteris, sold 39,541 shares on June 16 for approximately $1.71 million, representing nearly 15% of his direct stock holdings, indicating a cautious outlook on the company's future.
- Ownership Reduction: Following this transaction, Moll's direct ownership in Arteris has decreased by nearly 60%, raising concerns about his perspective on the company, even as its stock price has surged nearly 350% over the past 52 weeks.
- Market Reaction Analysis: While insider selling is often viewed negatively, studies suggest that only a minority of such sales predict stock price declines, prompting investors to interpret this information with caution.
- Investment Advice: Before investing in Arteris, investors should note that The Motley Fool's analyst team did not include it in their current list of top investment stocks, indicating a divergence in market sentiment regarding its future performance.
See More
Arteris CEO Sells 70,000 Shares Indirectly for $2.4 Million
- Transaction Overview: Arteris CEO K. Charles Janac reported the indirect sale of 70,000 shares on June 8, 2026, for approximately $2.4 million, indicating a shift in his ownership structure within the company.
- Ownership Change: Post-transaction, Janac's indirect holdings decreased to 8,985,323 shares, with direct holdings at 196,729 shares, totaling over 9.18 million shares, demonstrating his continued significant control over the company.
- Market Performance: The transaction occurred after Arteris shares appreciated by 416.37% over the past year, reflecting Janac's strategy in liquidity management following a substantial stock price increase.
- Trading Plan: This sale was executed under a pre-arranged 10b5-1 trading plan established in March 2025, indicating that Janac's sale was not based on insider information but rather adhered to a transparent and compliant trading strategy.
See More
Arteris CEO Sells 70,000 Shares Amid Stock Surge
- Sale Details: Arteris CEO K. Charles Janac sold 70,000 shares through Bayview Legacy, LLC on June 8, 2026, generating approximately $2.4 million at an average price of $34.91 per share, representing 0.76% of his indirect holdings.
- Stock Performance: This sale occurred during a period of significant appreciation, with Arteris shares experiencing a 416.37% increase over the past year, rising from a 52-week low of $8.01 to a high of $43.39 on June 15, indicating strong market performance.
- Trading Plan Context: Janac's sale was executed under a pre-arranged Rule 10b5-1 trading plan established in March 2025, indicating that the transaction was non-discretionary and not motivated by personal gain from the stock's surge, thus adhering to compliance protocols.
- Company Financials: Arteris reported $22.9 million in revenue for Q1 2026, reflecting a robust 39% year-over-year growth driven by strong demand in the AI sector, and despite the sale, Janac maintains a substantial equity position with over nine million shares, alleviating investor concerns.
See More
Arteris Director Sells 20,839 Shares Amid Stock Surge
- Transaction Overview: Antonio J. Viana disclosed the sale of 20,839 shares on June 4, 2026, with a transaction value of approximately $761,000, reducing his direct holdings to 4,704 shares while increasing indirect holdings via the Viana Family Trust to 64,620 shares, totaling 69,324 shares, or about 1.4% of his initial position.
- Proportion Analysis: This transaction represents 23.11% of Viana's total pre-transaction holdings, with direct holdings dropping to 4,704 shares and indirect holdings at 64,620 shares, indicating a significant shift in his ownership structure that may impact future trading capacity.
- Market Conditions and Timing: The shares were sold at a weighted average price of around $36.51, close to the closing price of $37.19 on the transaction date, occurring during a period when Arteris shares delivered a remarkable 332.28% total return over the past year, highlighting strong market performance.
- Investor Impact Assessment: Viana's share sale was executed under a pre-arranged Rule 10b5-1 trading plan established in June 2025 to avoid insider trading allegations; although conducted during a stock surge, it does not raise investor concerns and instead reflects the company's robust business performance and increasing customer demand.
See More
Arteris Director's Stock Sale Analysis
- Stock Sale Overview: On June 4, 2026, Arteris Director Antonio Viana sold 20,839 shares for approximately $761,000, with a weighted average sale price of $36.51 per share, representing 23.11% of his total holdings.
- Holding Changes: Following multiple sales, Viana's remaining shares now account for only 1.4% of his prior capacity, indicating a reduction in available shares rather than a shift in his disposition strategy, reflecting changes in market liquidity.
- Transaction Context: The stock sale occurred just a day after Arteris shares peaked at a 52-week high of $38.99, and it was a non-discretionary transaction executed under a pre-arranged Rule 10b5-1 trading plan established in June 2025, aimed at avoiding insider trading allegations.
- Company Performance: Arteris reported revenue of $22.9 million in Q1 2026, marking a 39% year-over-year growth, with sales driven by strong customer demand across sectors such as aerospace, defense, and artificial intelligence, highlighting the company's robust performance in high-growth markets.
See More
Arteris COO Sells 39,541 Shares for $1.71 Million
- Insider Selling: Laurent R Moll, COO of Arteris, disclosed a direct sale of 39,541 shares valued at approximately $1.71 million in his latest SEC filing, representing nearly 15% of his direct holdings and indicating a significant reduction in his stake.
- Ownership Changes: Post-transaction, Moll's direct holdings decreased to 227,296 shares, or about 0.49% of the company's outstanding shares, with 21 sales since March 2025 reducing his holdings by 57%, reflecting a continuous decline in his share capacity.
- Market Performance and Impact: While Moll's selling coincides with Arteris shares rallying nearly 348% over the past year, his frequent sales may raise investor concerns about the company's future performance, especially given that he has reduced his stake by nearly 60%.
- Investor Considerations: Although insider selling is often viewed as a negative signal, Moll's sales may relate to personal financial needs or wealth diversification, prompting investors to weigh his selling against Arteris's strong market performance when assessing the company.
See More
Arteris Insider Sale Raises Investor Concerns
- Insider Selling Details: Laurent R Moll, COO of Arteris, sold 39,541 shares on June 16 for approximately $1.71 million, representing nearly 15% of his direct stock holdings, indicating a cautious outlook on the company's future.
- Ownership Reduction: Following this transaction, Moll's direct ownership in Arteris has decreased by nearly 60%, raising concerns about his perspective on the company, even as its stock price has surged nearly 350% over the past 52 weeks.
- Market Reaction Analysis: While insider selling is often viewed negatively, studies suggest that only a minority of such sales predict stock price declines, prompting investors to interpret this information with caution.
- Investment Advice: Before investing in Arteris, investors should note that The Motley Fool's analyst team did not include it in their current list of top investment stocks, indicating a divergence in market sentiment regarding its future performance.
See More
Arteris CEO Sells 70,000 Shares Indirectly for $2.4 Million
- Transaction Overview: Arteris CEO K. Charles Janac reported the indirect sale of 70,000 shares on June 8, 2026, for approximately $2.4 million, indicating a shift in his ownership structure within the company.
- Ownership Change: Post-transaction, Janac's indirect holdings decreased to 8,985,323 shares, with direct holdings at 196,729 shares, totaling over 9.18 million shares, demonstrating his continued significant control over the company.
- Market Performance: The transaction occurred after Arteris shares appreciated by 416.37% over the past year, reflecting Janac's strategy in liquidity management following a substantial stock price increase.
- Trading Plan: This sale was executed under a pre-arranged 10b5-1 trading plan established in March 2025, indicating that Janac's sale was not based on insider information but rather adhered to a transparent and compliant trading strategy.
See More
Arteris CEO Sells 70,000 Shares Amid Stock Surge
- Sale Details: Arteris CEO K. Charles Janac sold 70,000 shares through Bayview Legacy, LLC on June 8, 2026, generating approximately $2.4 million at an average price of $34.91 per share, representing 0.76% of his indirect holdings.
- Stock Performance: This sale occurred during a period of significant appreciation, with Arteris shares experiencing a 416.37% increase over the past year, rising from a 52-week low of $8.01 to a high of $43.39 on June 15, indicating strong market performance.
- Trading Plan Context: Janac's sale was executed under a pre-arranged Rule 10b5-1 trading plan established in March 2025, indicating that the transaction was non-discretionary and not motivated by personal gain from the stock's surge, thus adhering to compliance protocols.
- Company Financials: Arteris reported $22.9 million in revenue for Q1 2026, reflecting a robust 39% year-over-year growth driven by strong demand in the AI sector, and despite the sale, Janac maintains a substantial equity position with over nine million shares, alleviating investor concerns.
See More
Arteris Director Sells 20,839 Shares Amid Stock Surge
- Transaction Overview: Antonio J. Viana disclosed the sale of 20,839 shares on June 4, 2026, with a transaction value of approximately $761,000, reducing his direct holdings to 4,704 shares while increasing indirect holdings via the Viana Family Trust to 64,620 shares, totaling 69,324 shares, or about 1.4% of his initial position.
- Proportion Analysis: This transaction represents 23.11% of Viana's total pre-transaction holdings, with direct holdings dropping to 4,704 shares and indirect holdings at 64,620 shares, indicating a significant shift in his ownership structure that may impact future trading capacity.
- Market Conditions and Timing: The shares were sold at a weighted average price of around $36.51, close to the closing price of $37.19 on the transaction date, occurring during a period when Arteris shares delivered a remarkable 332.28% total return over the past year, highlighting strong market performance.
- Investor Impact Assessment: Viana's share sale was executed under a pre-arranged Rule 10b5-1 trading plan established in June 2025 to avoid insider trading allegations; although conducted during a stock surge, it does not raise investor concerns and instead reflects the company's robust business performance and increasing customer demand.
See More
Arteris Director's Stock Sale Analysis
- Stock Sale Overview: On June 4, 2026, Arteris Director Antonio Viana sold 20,839 shares for approximately $761,000, with a weighted average sale price of $36.51 per share, representing 23.11% of his total holdings.
- Holding Changes: Following multiple sales, Viana's remaining shares now account for only 1.4% of his prior capacity, indicating a reduction in available shares rather than a shift in his disposition strategy, reflecting changes in market liquidity.
- Transaction Context: The stock sale occurred just a day after Arteris shares peaked at a 52-week high of $38.99, and it was a non-discretionary transaction executed under a pre-arranged Rule 10b5-1 trading plan established in June 2025, aimed at avoiding insider trading allegations.
- Company Performance: Arteris reported revenue of $22.9 million in Q1 2026, marking a 39% year-over-year growth, with sales driven by strong customer demand across sectors such as aerospace, defense, and artificial intelligence, highlighting the company's robust performance in high-growth markets.
See More
